Clinical Trials: A Phase 2 Trial of MLN8237, an Oral Aurora A Kinase Inhibitor, in Adult Patients With Aggressive Non-Hodgkin’s Lymphoma

Sponsor and Collaborators

Millennium Pharmaceuticals, Inc.

Contact

For an updated listing of recruitment sites contact: Millennium Medical and Drug Information Center

1-866-835-2233

[email protected]om

Principal Investigator

Medical Monitor Millennium Pharmaceuticals, Inc.

ClinicalTrials.gov Identifier